This project is dedicated to the development and characterization of mouse model systems that best reflectthe myelin and oligodendrocyte related (OMR) gene expression deficits in persons with schizophrenia.Several different genetically modified mouse model systems will be evaluated (e.g., Quaking, MAG,PTPRZ1, and Olig2. Each of these mouse model systems will be screened for deficits in the expression ofOMR genes using a panel of OMR genes that we have shown to be differentially affected in schizophrenia.Those that evidence gene expression deficits on at least 3 OMR genes known to be affected inschizophrenia will then be assessed for behavioral deficits. The behavioral phenotyping test battery willinclude screening tests of simple (e.g., reflexes, locomotion, balance, sensation) as well as complex(learning, memory, startle, prepulse inhibition of startle, social interaction, anxiety) behaviors. Coupled withthese purely behavioral tests will be pharmacological probes to ascertain whether pharmacological profilescommonly viewed as prototypical for rodent models of schizophrenia are also evidenced by the OMR genedeficient mice. Once 'best-fit' model systems have been identified, they will be studied longitudinally toascertain the evolution of gene expression and behavioral deficits from 3 months of age through to 18months of age. In addition, laser capture microdissection techniques will be employed to investigate geneexpression in identified cell groups. In collaboration with Project 1, the 'best-fit' mouse model system will besystematically imaged by DTI in vivo at ages corresponding to those for behavioral testing. In collaborationwith Project 3, brain tissue specimens from additional mice will be studied for changes in oligodendroglialproliferation, differentiation and survival. Significant progress has already been made in this regard. All ofthe behavioral test paradigms have been piloted and parameters have been optimized for use in mice in ourphenotyping facility (results and descriptions appended). Three of the 4 animal model systems proposed foruse (Quaking, Olig2, and MAG) have been obtained. Some studies have already been completed in thesemice and colonies have been established to enable more large scale studies.

Agency
National Institute of Health (NIH)
Institute
National Institute of Mental Health (NIMH)
Type
Specialized Center (P50)
Project #
5P50MH066392-06
Application #
7659502
Study Section
Special Emphasis Panel (ZMH1)
Project Start
2008-07-16
Project End
2012-05-31
Budget Start
2008-07-16
Budget End
2009-05-31
Support Year
6
Fiscal Year
2008
Total Cost
$233,644
Indirect Cost
Name
Icahn School of Medicine at Mount Sinai
Department
Type
DUNS #
078861598
City
New York
State
NY
Country
United States
Zip Code
10029
Fazio, Leonardo; Pergola, Giulio; Papalino, Marco et al. (2018) Transcriptomic context of DRD1 is associated with prefrontal activity and behavior during working memory. Proc Natl Acad Sci U S A 115:5582-5587
Gusev, Alexander; Mancuso, Nicholas; Won, Hyejung et al. (2018) Transcriptome-wide association study of schizophrenia and chromatin activity yields mechanistic disease insights. Nat Genet 50:538-548
Mitelman, Serge A; Bralet, Marie-Cecile; Mehmet Haznedar, M et al. (2018) Positron emission tomography assessment of cerebral glucose metabolic rates in autism spectrum disorder and schizophrenia. Brain Imaging Behav 12:532-546
Gandal, Michael J; Zhang, Pan; Hadjimichael, Evi et al. (2018) Transcriptome-wide isoform-level dysregulation in ASD, schizophrenia, and bipolar disorder. Science 362:
Girdhar, Kiran; Hoffman, Gabriel E; Jiang, Yan et al. (2018) Cell-specific histone modification maps in the human frontal lobe link schizophrenia risk to the neuronal epigenome. Nat Neurosci 21:1126-1136
Hauberg, Mads E; Fullard, John F; Zhu, Lingxue et al. (2018) Differential activity of transcribed enhancers in the prefrontal cortex of 537 cases with schizophrenia and controls. Mol Psychiatry :
Agrawal, A; Chou, Y-L; Carey, C E et al. (2018) Genome-wide association study identifies a novel locus for cannabis dependence. Mol Psychiatry 23:1293-1302
Curtis, David (2018) Polygenic risk score for schizophrenia is not strongly associated with the expression of specific genes or gene sets. Psychiatr Genet 28:59-65
Dobbyn, Amanda; Huckins, Laura M; Boocock, James et al. (2018) Landscape of Conditional eQTL in Dorsolateral Prefrontal Cortex and Co-localization with Schizophrenia GWAS. Am J Hum Genet 102:1169-1184
Gandal, Michael J; Haney, Jillian R; Parikshak, Neelroop N et al. (2018) Shared molecular neuropathology across major psychiatric disorders parallels polygenic overlap. Science 359:693-697

Showing the most recent 10 out of 153 publications